WEBULL
WebtradeDownload

Why thyssenkrupp nucera KGaA (XTRA:NCH2) Could Be 26% Undervalued As Guidance Resets Expectations

Simply Wall St · 2d ago

thyssenkrupp nucera KGaA (XTRA:NCH2) issued fresh guidance for its 2025/26 third quarter and first nine months, indicating expected quarterly sales of €145 million and a loss before interest and taxes of about €2 million.

See our latest analysis for thyssenkrupp nucera KGaA.

At a share price of €7.90, thyssenkrupp nucera KGaA has seen short term share price momentum improve, with a 7 day share price return of 4.02% and 30 day share price return of 3.88%. However, longer term total shareholder return over one and three years remains weak at 19.72% and 64.25% declines. Updated guidance on sales and losses is likely shaping how investors weigh near term execution risk against the longer term potential of its electrolysis and green hydrogen projects.

If this update has you rethinking where growth could come from next, it may be worth scanning other companies in power infrastructure and grid technology via the 36 power grid technology and infrastructure stocks

For thyssenkrupp nucera KGaA, the recent lift in the share price sits against years of weak total returns and ongoing losses. Is this latest move pointing to better alignment with fundamentals, or just a short term shift in sentiment before the next valuation check?

Most Popular Narrative: 26.4% Undervalued

Against the last close of €7.90, the most followed narrative for thyssenkrupp nucera KGaA points to a fair value of €10.74, built on detailed assumptions about long dated hydrogen orders and future profitability.

The increasing volume of paid FEED (Front-End Engineering Design) and engineering contracts, especially in Europe, which remains the most active region for green hydrogen, signals forthcoming conversion into firm, large-scale orders within 6-12 months, offering improved medium-term revenue visibility.

Read the complete narrative. Read the complete narrative.

Want to understand why this fair value sits well above today’s price? The narrative leans on meaningful revenue expectations, a sharp profit swing and a premium earnings multiple. Curious which specific margin and growth assumptions need to land for that story to hold?

Result: Fair Value of €10.74 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the current thyssenkrupp nucera KGaA narrative still hinges on a few large green hydrogen projects and on the timely conversion of FEED work into firm orders.

Find out about the key risks to this thyssenkrupp nucera KGaA narrative.

Another View on thyssenkrupp nucera KGaA’s Valuation

While the narrative fair value of €10.74 suggests thyssenkrupp nucera KGaA is undervalued, the current P/S ratio of 1.8x tells a different story. It sits well above the European Construction industry at 0.6x, the peer average at 1.1x, and the fair ratio of 0.5x, which points to valuation risk if expectations slip.

If you prefer to let the numbers guide you, it may be worth comparing this premium against the detailed breakdown in our valuation workup, then asking yourself what would need to change before the market moved closer to that fair ratio. See what the numbers say about this price — find out in our valuation breakdown.

XTRA:NCH2 P/S Ratio as at Aug 2026
XTRA:NCH2 P/S Ratio as at Aug 2026

Next Steps

With sentiment on thyssenkrupp nucera KGaA still split between recent weakness and future rewards, it makes sense to review the evidence yourself and move quickly to form your own view. To understand what is driving the optimism on the reward side, take a closer look at the 1 key reward

Looking for more investment ideas beyond thyssenkrupp nucera KGaA?

If thyssenkrupp nucera KGaA has sharpened your focus on where returns might come from next, it makes sense to widen your search using targeted stock screeners.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.